Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Amgen
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
Efficacy and Safety Study of Romiplostim in Paediatrics with Immune Thrombocytopenia
The primary objective is to evaluate the efficacy of romiplostim in the treatment of thrombocytopenia in pediatric subjects with immune thrombocytopenia (ITP) as measured by durable platelet response.
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A study to evaluate the safety of panitumumab and children with solid tumours
To evaluate the safety and pharmacokinetics (PK) of up to 3 different dose schedules of panitumumab in pediatric subjects with solid tumors.
Country
None
organs
None
Specialty
None
More information
Woman
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen 20060341 : Essai de phase 2 randomisé, en double aveugle, évaluant l’efficacité et la tolérance d’un traitement de 1ère ligne par AMG 386 associé au paclitaxel et au bévacizumab chez des patientes ayant un cancer du sein. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A randomized, 4-arm, placebo-controlled phase 2 trial of AMG 386 in combination with bevacizumab and paclitaxel or AMG 386 plus paclitaxel as first-line therapy in subjects with HER2-negative, metasta...
Country
France
organs
Sein
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
An international research study to find out more about darbepoetin alfa in people with Myelodysplastic Syndrome (MDS) and anaemia. This study will see if darbepoetin alfa increases your haemoglobin levels and whether it causes any side effects. To do this, darbepoetin alfa will be compared to placebo. The placebo will look like the darbepoetin alfa but it will not contain any active ingredients. Taking placebo is the same as not taking any medication for your anaemia. Es un estudio de investigación internacional para averiguar más acerca de darbepoetin alfa en personas con síndrome mielodisplásico (SMD) y la anemia. Este estudio quiere ver si darbepoetin alfa aumenta sus niveles de hemoglobina y si causa efectos secundarios. Para ello, darbepoetina alfa se compara con un placebo. El placebo se parecerá a darbepoetina alfa, pero no contiene ningún prinicpio activo. Tomar placebo es lo mismo que no tomar ningún medicamento para tratar su anemia
To assess the superiority of darbepoetin alfa treatment compared with placebo on the proportion of subjects achieving International Working Group (IWG) erythroid response during the 24-week double-bli...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects with Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The primary objective of this study is to evaluate the safety of romiplostim in adult thrombocytopenic subjects with ITP.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Amgen, Inc
Update Il y a 4 ans
A Randomized, Double-Blind, Trial of AMG 745 or Placebo for the Treatment of Cachexia in Subjects with Non-Small Cell Lung Cancer
To evaluate the effect of AMG 745 on strength in subjects with cachexia due to NSCLC and to evaluate the safety and tolerability profile of AMG 745 in this patient population.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
Amgen SPECTRUM : Essai de phase 3 randomisé évaluant l’efficacité d’une chimiothérapie associée ou non au panitumumab (Vectibix®) chez des patients ayant un carcinome squameux de la tête et du cou métastatique ou en récidive. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’efficacité du panitumumab (Vectibix®) en association avec une chimiothérapie dans le traitement des patients ayant un carcinome squameux de la tête et du cou. ...
Country
France
organs
Tête et cou
Specialty
Thérapies Ciblées
,
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 6 ans
Etude JASMINE : étude de phase 3 randomisée en double aveugle visant à évaluer l’efficacité, la sécurité et l’immunogénicité de l’APB798 en comparaison au rituximab chez des patients ayant un lymphome non hodgkinien (LNH) à cellules B CD20 positif.
Le lymphome non hodgkinien est un cancer qui se développe à partir de cellules du système lymphatiques, les lymphocytes B ou T (globules blancs impliqués dans les réactions de défense de l’organisme)....
Country
France
organs
Lymphomes non hodgkinien
Specialty
Immunothérapie - Vaccinothérapie
Essai ouvert aux inclusions
More information
Woman and Man
Between 18 years
and 99 years
Amgen
Update Il y a 4 ans
PAVES : Essai de phase 3 randomisé, en double aveugle, évaluant l’efficacité du pelfilgrastim dans la prévention des neutropénies chez des patients ayant un cancer colorectal localement avancé ou métastatique, recevant un traitement de première ligne par bévacizumab et chimiothérapie de type FOLFOX ou FOLFIRI. [essai clos aux inclusions]
L’objectif de cet essai est d’évaluer l’efficacité du pegfilgrastim dans la prévention des neutropénies chez des patients ayant un cancer colorectal localement avancé ou métastatique, recevant un trai...
Country
France
organs
Côlon ou Rectum (colorectal)
Specialty
Chimiothérapie
,
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Amgen Limited
Update Il y a 4 ans
Randomized Trial to Evaluate the Efficacy and Safety of Cinacalcet Treatment in Combination with Low Dose Vitamin D for the Treatment of Subjects with Secondary Hyperparathyroidism (SHPT) Recently Initiating Hemodialysis
To evaluate the ability of a treatment strategy that includes the use of cinacalcet in combination with low dose active vitamin D sterols (if prescribed) to control parathyroid hormone (PTH) compared ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
12
13
14
15
16
17
18
19
20
21
Next